Nature报道:安德森癌症中心重大突破——外泌体还能用于胰腺癌治疗

2017-06-09 佚名 生物探索

6月7日Nature在线发表了安德森癌症中心Raghu Kalluri教授新的研究进展:修饰过后的外泌体可以递送iRNA,用于胰腺癌的治疗。外泌体上的CD47避免其被免疫细胞吞噬,在这项研究之前,直接特异性靶向KRAS一直很难做到。生物探索专访过的安德森癌症中心的Raghu Kalluri教授又有了新的研究进展:对于外泌体的遗传操作,可能为胰腺癌提供一种新的治疗方法。相关文章于6月7日在Natur

6月7日Nature在线发表了安德森癌症中心Raghu Kalluri教授新的研究进展:修饰过后的外泌体可以递送iRNA,用于胰腺癌的治疗。外泌体上的CD47避免其被免疫细胞吞噬,在这项研究之前,直接特异性靶向KRAS一直很难做到。

生物探索专访过的安德森癌症中心的Raghu Kalluri教授又有了新的研究进展:对于外泌体的遗传操作,可能为胰腺癌提供一种新的治疗方法。相关文章于6月7日在Nature在线发表。

Raghu Kalluri教授之前的研究确定了外泌体可以用来诊断胰腺癌,但这些最新的发现是让基因工程修饰的外泌体获得新的功能——直接和特异性靶向突变的KRAS基因,这个基因通常和胰腺癌相关。

修饰过的外泌体能递送RNAi

在这项研究中,通常由细胞产生、存在于血液中的外泌体被修饰为"iExosomes",能够将小RNA递送到特异靶向的突变KRAS基因,导致疾病的抑制和在小鼠模型中总的生存率增加。当通过这些天然的纳米颗粒——外泌体进行递送时,研究人员利用一种称为RNA干扰(RNAi)的靶向方法。研究表明,外泌体能够作为RNAi的有效载体,进入包括癌细胞的各种细胞。

当发生突变后,KRAS基因作为分子开关,被困在“开”的位置。它是在百分之80到95胰腺导管腺癌(PDAC)中最常见的突变。研究表明,iExosomes能够提供称为siRNA和shRNA的KRAS基因特异的靶向物质,比他们的合成类似物——iLiposomes更高效,而且有自然的复杂性和优势。

CD47避免其被免疫细胞吞噬

该研究不仅表明和脂质体相比,外泌体有卓越的递送siRNA分子的能力和并能抑制侵袭性胰腺肿瘤生长。研究还表明外泌体上CD47的存在可以避免被循环单核细胞吞噬。

CD47是许多细胞过程中所涉及的蛋白质,包括细胞死亡、生长和迁移。吞噬作用是被称为巨噬细胞的白细胞消化细胞碎片、异物和颗粒的过程。单核细胞是对免疫系统有重要意义的白细胞中最大的一类。CD47主要负责发起“不要吃我”的信号,抑制吞噬作用。研究人员确定了CD47是如何有助于在循环系统中抑制清除外泌体,增强了输送到胰腺癌细胞的效果。

按目前的治疗标准,PDAC患者的预后很差,有效的新的治疗方法是必要的。PDAC的遗传分析表明,KRAS突变存在于大多数患者中,在癌症的起始、发展和转移中也起着重要作用。通过用遗传方法抑制癌基因KRAS来抑制肿瘤的进展,存在其他遗传缺陷。在这项研究之前,直接特异性靶向KRAS一直很难做到。

胞饮作用有促进效果尚需进一步研究

研究还发现细胞摄入养分和囊泡的胞饮过程,有助于有突变KRAS的癌细胞摄入外泌体。研究人员介绍增加的胞饮作用也增加了外泌体到达胰腺的数量,可能对进入KRAS突变相关的癌细胞有促进作用。需要进一步的研究来更好地了解外泌体是否通过胞饮作用进入细胞,能否通过其他方面提高其抗肿瘤的能力。

之前关于Raghu Kalluri教授的报道(详细)

德克萨斯大学癌症生物学系Raghu Kalluri教授也是该校MD安德森癌症中心癌转移研究中心的主任。在2015年Kalluri教授的实验室因发现能检测出来早期阶段的胰腺癌(在它扩散到其它器官,变得很难处理之前)的血液检测的方法而受到广泛关注。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1882152, encodeId=c0a2188215261, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jan 27 22:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250249, encodeId=c1882502491e, content=中国患者怎么能接受到治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1a2164169, createdName=1203abadm55暂无昵称, createdTime=Wed Oct 04 09:13:06 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221886, encodeId=55e82218866c, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/df2ef9fc2a193c8810bc7fe0421e7daf.jpg, createdBy=d2f61706602, createdName=宇文, createdTime=Thu Jul 13 15:04:39 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211206, encodeId=cb972112060c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 19:50:13 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208830, encodeId=6841208830dc, content=外泌体用于胰腺癌的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jun 10 07:04:11 CST 2017, time=2017-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208601, encodeId=940b20860116, content=好文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Fri Jun 09 13:38:56 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208586, encodeId=d3af20858615, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Fri Jun 09 10:43:15 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2018-01-27 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1882152, encodeId=c0a2188215261, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jan 27 22:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250249, encodeId=c1882502491e, content=中国患者怎么能接受到治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1a2164169, createdName=1203abadm55暂无昵称, createdTime=Wed Oct 04 09:13:06 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221886, encodeId=55e82218866c, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/df2ef9fc2a193c8810bc7fe0421e7daf.jpg, createdBy=d2f61706602, createdName=宇文, createdTime=Thu Jul 13 15:04:39 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211206, encodeId=cb972112060c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 19:50:13 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208830, encodeId=6841208830dc, content=外泌体用于胰腺癌的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jun 10 07:04:11 CST 2017, time=2017-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208601, encodeId=940b20860116, content=好文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Fri Jun 09 13:38:56 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208586, encodeId=d3af20858615, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Fri Jun 09 10:43:15 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-10-04 1203abadm55暂无昵称

    中国患者怎么能接受到治疗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1882152, encodeId=c0a2188215261, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jan 27 22:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250249, encodeId=c1882502491e, content=中国患者怎么能接受到治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1a2164169, createdName=1203abadm55暂无昵称, createdTime=Wed Oct 04 09:13:06 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221886, encodeId=55e82218866c, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/df2ef9fc2a193c8810bc7fe0421e7daf.jpg, createdBy=d2f61706602, createdName=宇文, createdTime=Thu Jul 13 15:04:39 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211206, encodeId=cb972112060c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 19:50:13 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208830, encodeId=6841208830dc, content=外泌体用于胰腺癌的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jun 10 07:04:11 CST 2017, time=2017-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208601, encodeId=940b20860116, content=好文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Fri Jun 09 13:38:56 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208586, encodeId=d3af20858615, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Fri Jun 09 10:43:15 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-07-13 宇文

    学习了!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1882152, encodeId=c0a2188215261, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jan 27 22:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250249, encodeId=c1882502491e, content=中国患者怎么能接受到治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1a2164169, createdName=1203abadm55暂无昵称, createdTime=Wed Oct 04 09:13:06 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221886, encodeId=55e82218866c, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/df2ef9fc2a193c8810bc7fe0421e7daf.jpg, createdBy=d2f61706602, createdName=宇文, createdTime=Thu Jul 13 15:04:39 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211206, encodeId=cb972112060c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 19:50:13 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208830, encodeId=6841208830dc, content=外泌体用于胰腺癌的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jun 10 07:04:11 CST 2017, time=2017-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208601, encodeId=940b20860116, content=好文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Fri Jun 09 13:38:56 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208586, encodeId=d3af20858615, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Fri Jun 09 10:43:15 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-06-15 luominglian113

    学习了,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1882152, encodeId=c0a2188215261, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jan 27 22:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250249, encodeId=c1882502491e, content=中国患者怎么能接受到治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1a2164169, createdName=1203abadm55暂无昵称, createdTime=Wed Oct 04 09:13:06 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221886, encodeId=55e82218866c, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/df2ef9fc2a193c8810bc7fe0421e7daf.jpg, createdBy=d2f61706602, createdName=宇文, createdTime=Thu Jul 13 15:04:39 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211206, encodeId=cb972112060c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 19:50:13 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208830, encodeId=6841208830dc, content=外泌体用于胰腺癌的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jun 10 07:04:11 CST 2017, time=2017-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208601, encodeId=940b20860116, content=好文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Fri Jun 09 13:38:56 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208586, encodeId=d3af20858615, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Fri Jun 09 10:43:15 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-06-10 jyzxjiangqin

    外泌体用于胰腺癌的治疗。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1882152, encodeId=c0a2188215261, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jan 27 22:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250249, encodeId=c1882502491e, content=中国患者怎么能接受到治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1a2164169, createdName=1203abadm55暂无昵称, createdTime=Wed Oct 04 09:13:06 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221886, encodeId=55e82218866c, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/df2ef9fc2a193c8810bc7fe0421e7daf.jpg, createdBy=d2f61706602, createdName=宇文, createdTime=Thu Jul 13 15:04:39 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211206, encodeId=cb972112060c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 19:50:13 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208830, encodeId=6841208830dc, content=外泌体用于胰腺癌的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jun 10 07:04:11 CST 2017, time=2017-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208601, encodeId=940b20860116, content=好文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Fri Jun 09 13:38:56 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208586, encodeId=d3af20858615, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Fri Jun 09 10:43:15 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-06-09 蔬菜

    好文章,学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1882152, encodeId=c0a2188215261, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jan 27 22:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250249, encodeId=c1882502491e, content=中国患者怎么能接受到治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1a2164169, createdName=1203abadm55暂无昵称, createdTime=Wed Oct 04 09:13:06 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221886, encodeId=55e82218866c, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/df2ef9fc2a193c8810bc7fe0421e7daf.jpg, createdBy=d2f61706602, createdName=宇文, createdTime=Thu Jul 13 15:04:39 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211206, encodeId=cb972112060c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 19:50:13 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208830, encodeId=6841208830dc, content=外泌体用于胰腺癌的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jun 10 07:04:11 CST 2017, time=2017-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208601, encodeId=940b20860116, content=好文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Fri Jun 09 13:38:56 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208586, encodeId=d3af20858615, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Fri Jun 09 10:43:15 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-06-09 楠博One

    学习谢谢分享

    0

相关资讯

PNAS:重磅:华人科学家在外泌体液体活检领域取得重大突破

近日,普渡大学陶纬国(W. Andy Tao)教授团队在癌症的液体活检领域做出了「突破性贡献」,他们通过分析血液中囊泡(extracellular vesicles,EVs;包括近几年颇受业界关注的外泌体在内)内的磷酸化蛋白,实现了检测癌症的目的。

号外---景杰生物正式开通外泌体蛋白质组/修饰组学服务啦!!

编者按:作为蛋白质组学科研服务领域的领跑者,景杰生物一直致力于为客户提供最专业、 深入的蛋白组学/修饰组学的技术服务。我们秉承着“一流人才、一流技术、一流效率”的理念,以“精准医疗”驱动人类健康事业为己任,致力将蛋白质组学技术引入更多的生物学研究领域,服务于有需求的科研工作者。如今我们要开展外泌体的蛋白质组学及修饰组学技术服务啦! 什么是外泌体 外泌体(Exosome)是一种由细胞分泌的

SCI REP:骨关节炎患者会出现性别特异性外泌体miRNA表达

目前,关于骨关节炎(OA)的发病机制知之甚少,对其治疗方法也仅限于预防疾病发展。最近的研究表明,外来体在细胞间细胞传播和许多年龄相关疾病的发病机理中起重要作用。滑膜衍生的外来miRNAs的分子分析可能增加我们对OA进展的理解,并可能导致发现新的生物标志物和治疗靶点。

JCEM:外泌体miRNA或是子痫前期的生物标志物

子痫前期(preeclampsia,PE,又称为先兆子痫)的发生率大约为3~5%,并不少见,是妊娠特发性疾病,高危因素有很多,但如果发现得早是完全可以治疗的。因此,制定早期预测子痫前期的策略是必要的,以制定PE预防策略,进而减少疾病的发生率和相关并发症,及减轻疾病的严重程度。来自澳大利亚昆士兰大学的研究人员探讨了母体循环中外泌体及其microRNA是否可以作为PE的早期生物标志物。本研究是一个回顾

CANCER GENE THER:消化系统癌症重要标记物-外泌体研究进展

外泌体的最重要的生物学功能是它们可能用作临床诊断中的生物标志物。与在常规标本例如血清或尿中鉴定的生物标志物相比,外泌体生物标志物提供最高量的灵敏度和特异性,这可归因于它们优异的稳定性。

SCI REP:外泌体中的miRNA可作为川崎病诊断标志

川崎病(Kawasaki disease),是一种以全身血管炎变为主要病理的急性发热性出疹性小儿疾病。虽然已有的研究已经发现一些血来源的蛋白分子或者miRNA有潜在的诊断能力,但是,其有效性还有待提高。外泌体,一种包含了细胞特异性信息的囊泡结构,保护了内部的分子免受胞外酶类的降解。因此,通过检测外泌体中的遗传物质,是寻找可靠诊断biomarker的理想方式。